Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Researchers at the Lausanne University Hospital (CHUV) in Switzerland have initiated pioneering research applying Chimeric Antigen Receptor (CAR) T-cell technology—traditionally used in oncology—to treat severe allergic asthma. By genetically reprogramming ... Read More
Continuous Coverage
Two Atlanta Braves position players are initiating formal rehabilitation assignments this Monday, marking a critical phase in their…
Antoinette Bower, Perennial Character Actor and Star Trek Alum, Dies at 93 Antoinette Bower, the British-American actress known…
Nadia Comăneci, the Romanian gymnastics legend, recently commemorated the 50th anniversary of her historic “Perfect 10” at the…
A newly proposed theoretical framework for dark matter, published this July, suggests that the mysterious substance may interact…
Nvidia (NASDAQ: NVDA) has slashed its list of authorized Asia-based distributors and sub-distributors by approximately 50%, a strategic…
Members of Parliament are signaling a significant shift in fiscal policy, urging Andy Burnham, the Mayor of Greater…
Global Affairs
State Route 89A near Flagstaff, Arizona, has officially reopened following temporary closures that disrupted critical transit corridors. Managed…
Markets And Money
Thermal Inefficiency in Residential Real Estate: The Hidden Cost of Climate Vulnerability Residents in Dutch high-rise housing are…
Digital Culture
Brook Gaming has officially launched the “Sniper 2,” a flagship keyboard and mouse converter designed to eliminate input…
Science And Wellbeing
A 56-year-old former Bundesliga footballer remains in a medically induced coma following emergency surgery for an acute aortic…
Screen And Sound
Big Cass is set to make his return to WWE television on August 3, 2026, following a cryptic…
Fixtures And Form
Scottie Scheffler and Rory McIlroy enter the 2026 Open Championship at Royal Birkdale as the prohibitive favorites, backed…
